Literature DB >> 27641224

Endovascular "neobranching" to manage acute aortic syndrome.

Isabelle L Vandormael1, Mohammad Y Salmasi1, James S-M Yeh1, Christoph A Nienaber1.   

Abstract

Acute aortic syndrome was coined in 2001 to describe a spectrum of acute aortic wall pathologies. The syndrome represents a cluster of aortic conditions such as aortic dissection, intramural hematoma and penetrating atherosclerotic ulcer. Acute aortic dissection is more common than the latter two pathologies with an incidence of up to 6 cases per 100,000 per year. The following report focuses on an unusual case presentation emphasizing the newest management techniques including "neobranching" whilst dealing with challenging patient anatomy and refractory hypertension. We believe this case report eventually broadens our understanding of acute aortic syndrome whilst addressing an entry tear outside the aorta by placing "neobranches".
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  acute aortic syndrome; aortic disease; aortic repair; endovascular; endovascular intervention; interventional devices/innovation; stent graft; stenting technique

Mesh:

Year:  2016        PMID: 27641224     DOI: 10.1002/ccd.26726

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  3 in total

1.  Novel reconstruction of a vascular aneurysm in Marfan syndrome.

Authors:  Xun Yuan; Andreas Mitsis; Christoph A Nienaber
Journal:  J Vis Surg       Date:  2018-04-03

2.  Visceral malperfusion after thoracic endovascular aortic repair for type B aortic dissection in a post-abdominal aortic grafting patient.

Authors:  Masaki Yamamoto; Miwa Tashiro; Tatsuya Noguchi; Kazumasa Orihashi
Journal:  J Cardiol Cases       Date:  2018-05-31

3.  Interventional repair of a vascular aneurysm in a patient with Marfan syndrome.

Authors:  Mohammed E Ghonem; Xun Yuan; Andreas Mitsis; Christoph A Nienaber
Journal:  SAGE Open Med Case Rep       Date:  2018-07-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.